Surgepays Stock Total Debt
| SURG Stock | USD 3.33 0.19 5.40% |
Surgepays fundamentals help investors to digest information that contributes to Surgepays' financial success or failures. It also enables traders to predict the movement of Surgepays Stock. The fundamental analysis module provides a way to measure Surgepays' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Surgepays stock.
The current Total Debt To Capitalization is estimated to decrease to 0.14. Surgepays | Total Debt |
Surgepays Company Total Debt Analysis
Surgepays' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Surgepays Total Debt | 5.44 M |
Most of Surgepays' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Surgepays is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Surgepays Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for Surgepays is extremely important. It helps to project a fair market value of Surgepays Stock properly, considering its historical fundamentals such as Total Debt. Since Surgepays' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Surgepays' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Surgepays' interrelated accounts and indicators.
Click cells to compare fundamentals
Surgepays Total Debt Historical Pattern
Today, most investors in Surgepays Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Surgepays' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Surgepays total debt as a starting point in their analysis.
Surgepays Total Debt |
| Timeline |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Surgepays Net Debt
Net Debt |
|
Based on the latest financial disclosure, Surgepays has a Total Debt of 5.44 M. This is 99.66% lower than that of the Wireless Telecommunication Services sector and significantly higher than that of the Communication Services industry. The total debt for all United States stocks is 99.9% higher than that of the company.
Surgepays Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Surgepays' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Surgepays could also be used in its relative valuation, which is a method of valuing Surgepays by comparing valuation metrics of similar companies.Surgepays is currently under evaluation in total debt category among related companies.
Surgepays Institutional Holders
Institutional Holdings refers to the ownership stake in Surgepays that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Surgepays' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Surgepays' value.| Shares | State Street Corporation | 2023-12-31 | 30.4 K | Blair William & Co | 2023-12-31 | 26.3 K | Gsa Capital Partners Llp | 2023-12-31 | 21 K | Jump Financial, Llc | 2023-12-31 | 16.5 K | Victory Capital Management Inc. | 2023-12-31 | 16.4 K | Cubist Systematic Strategies, Llc | 2023-12-31 | 16.1 K | Fny Investment Advisers, Llc | 2023-12-31 | 14.8 K | Advisor Group Holdings, Inc. | 2023-12-31 | 13 K | Ausdal Financial Partners Inc | 2023-12-31 | 12.7 K | Vanguard Group Inc | 2023-12-31 | 467.2 K | Myda Advisors Llc | 2023-12-31 | 136.5 K |
Surgepays Fundamentals
| Return On Equity | 1.23 | ||||
| Return On Asset | 0.31 | ||||
| Profit Margin | 0.15 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 58.78 M | ||||
| Shares Outstanding | 19.28 M | ||||
| Shares Owned By Insiders | 29.47 % | ||||
| Shares Owned By Institutions | 7.46 % | ||||
| Number Of Shares Shorted | 1.04 M | ||||
| Price To Earning | 11.14 X | ||||
| Price To Book | 2.72 X | ||||
| Price To Sales | 0.56 X | ||||
| Revenue | 137.14 M | ||||
| Gross Profit | 13.47 M | ||||
| EBITDA | 19.97 M | ||||
| Net Income | 20.62 M | ||||
| Cash And Equivalents | 8.7 M | ||||
| Cash Per Share | 0.70 X | ||||
| Total Debt | 5.44 M | ||||
| Debt To Equity | 6.32 % | ||||
| Current Ratio | 1.07 X | ||||
| Book Value Per Share | 1.96 X | ||||
| Cash Flow From Operations | 10.29 M | ||||
| Short Ratio | 1.04 X | ||||
| Earnings Per Share | 1.38 X | ||||
| Target Price | 7.0 | ||||
| Number Of Employees | 22 | ||||
| Beta | 1.48 | ||||
| Market Capitalization | 66.33 M | ||||
| Total Asset | 42.15 M | ||||
| Retained Earnings | (15.19 M) | ||||
| Working Capital | 20.66 M | ||||
| Current Asset | 46.28 M | ||||
| Current Liabilities | 9.69 M | ||||
| Net Asset | 42.15 M |
About Surgepays Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Surgepays's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Surgepays using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Surgepays based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Surgepays is a strong investment it is important to analyze Surgepays' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Surgepays' future performance. For an informed investment choice regarding Surgepays Stock, refer to the following important reports:Check out Surgepays Piotroski F Score and Surgepays Altman Z Score analysis. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Surgepays Stock analysis
When running Surgepays' price analysis, check to measure Surgepays' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgepays is operating at the current time. Most of Surgepays' value examination focuses on studying past and present price action to predict the probability of Surgepays' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgepays' price. Additionally, you may evaluate how the addition of Surgepays to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |
Is Surgepays' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgepays. If investors know Surgepays will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgepays listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.17) | Earnings Share 1.38 | Revenue Per Share 9.618 | Quarterly Revenue Growth (0.11) | Return On Assets 0.3106 |
The market value of Surgepays is measured differently than its book value, which is the value of Surgepays that is recorded on the company's balance sheet. Investors also form their own opinion of Surgepays' value that differs from its market value or its book value, called intrinsic value, which is Surgepays' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgepays' market value can be influenced by many factors that don't directly affect Surgepays' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surgepays' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgepays is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgepays' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.